Clinical Trials Logo

Sterility clinical trials

View clinical trials related to Sterility.

Filter by:

NCT ID: NCT02607319 Completed - Sterility Clinical Trials

Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure

BRIF
Start date: November 2015
Phase: Phase 4
Study type: Interventional

The objective of this study is to determine the effect of Bemiparin, a low molecular weight heparin, on implantation rate in women with unexplained recurrent implantation failure undergoing IVF/ICSI treatment.

NCT ID: NCT01955356 Completed - Sterility Clinical Trials

Embryo Implantation After Induced Endometrial Injury

Start date: October 2013
Phase: N/A
Study type: Interventional

Some studies have revealed that an induced endometrial injury could improve embryo human implantation in patients with implantation failure. The purpose of this study is to determine whether the induced endometrial injury could be beneficial for regular patients undergoing IVF

NCT ID: NCT01430650 Completed - Sterility Clinical Trials

Endometrial Priming for Embryo Transfer

Start date: July 2010
Phase: Phase 4
Study type: Interventional

The aim of this trial is compare two different endometrial priming protocols - women that receive oral estrogens - women that receive transdermal estrogens

NCT ID: NCT01406964 Completed - Sterility Clinical Trials

Chlamidia Antibodies Test for Tubal Factor Screening

Start date: July 2011
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

NCT ID: NCT01331733 Completed - Sterility Clinical Trials

Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist

PROMENIA
Start date: November 2006
Phase: N/A
Study type: Observational

To assess the effectiveness of protocols of ovarian hyperstimulation combining urinary gonadotrophins + GnRH antagonist vs urinary gonadotrophins, to achieve clinical pregnancy in females undergoing intrauterine insemination. Study hypothesis: protocols combining urinary gonadotrophins + GnRH antagonist should be more effective than monotherapy.

NCT ID: NCT01331720 Completed - STERILITY Clinical Trials

Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation

DESCARTES
Start date: November 2007
Phase: N/A
Study type: Observational

The aim of the study is to assess the effectiveness of 5 mixed protocols of ovarian hyperstimulation with urinary gonadotrophins to achieve clinical pregnancy in females undergoing assisted reproductive techniques (IVF/ICSI) (in-vitro fertilisation/intracytoplasmic sperm injection). Study hypothesis: mixed protocols with urinary FSH (follicle-stimulating hormone) and urinary hMG (human menopausal gonadotropin)should be more effective than monotherapy.

NCT ID: NCT01330784 Completed - Sterility Clinical Trials

Assessment of the Therapeutic Utility of hMG-HP

Start date: October 2006
Phase: N/A
Study type: Observational

To assess the effectiveness of a protocol of ovarian hyperstimulation with urinary gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of a protocol of urinary gonadotrophins

NCT ID: NCT01330771 Completed - Sterility Clinical Trials

Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP

Start date: October 2006
Phase: N/A
Study type: Observational

To assess the effectiveness of a protocol of ovarian hyperstimulation combining urinary gonadotrophins + recombinant gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of protocols combining urinary gonadotrophins + recombinant gonadotrophins

NCT ID: NCT00749853 Suspended - Sterility Clinical Trials

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Start date: May 2015
Phase: Phase 3
Study type: Interventional

Available data from in vitro studies and clinical trials indicate that genetic factors play a significant role in the success of controlled ovarian stimulation (COS) prior to in vitro fertilization - embryo trandfer (IVF-ET). Women with the FSHR Ser680Asn Ser/Ser genotype make up between 13% and 26% of women undergoing IVF-ET and are characterised by higher basal FSH serum concentrations, the need for a higher amount of FSH for COS, and a higher risk of poor response to COS and cycle cancellation. The investigators therefore intend to perform a study to investigate whether a dose-intensified COS protocol based on FSHR genotype status in women with the FSHR Ser680Asn Ser/Ser genotype is more effective than routine management in terms of - the mean number of follicles - the mean number of embryos - the rate of poor responders - the rate of women with cycle cancellations, and v) the clinical pregnancy rates. Eligible women will be randomized to a stimulation protocol characterised by a longer duration and increased dosage of FSH stimulation (group A) or a standard stimulation protocol (group B).